Barclays’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Sell |
591
-11,879
| -95% | -$80.4K | ﹤0.01% | 4228 |
|
|
2025
Q1 | $66K | Sell |
12,470
-5,686
| -31% | -$30.1K | ﹤0.01% | 3813 |
|
|
2024
Q4 | $215K | Sell |
18,156
-20,306
| -53% | -$240K | ﹤0.01% | 3480 |
|
|
2024
Q3 | $792K | Sell |
38,462
-53,266
| -58% | -$1.1M | ﹤0.01% | 2754 |
|
|
2024
Q2 | $4.15M | Sell |
91,728
-93,420
| -50% | -$4.23M | ﹤0.01% | 1269 |
|
|
2024
Q1 | $7.27M | Buy |
+185,148
| New | +$7.27M | ﹤0.01% | 1185 |
|
|
2022
Q1 | – | Sell |
-1,700
| Closed | -$31K | – | 4772 |
|
|
2021
Q4 | $31K | Sell |
1,700
-487
| -22% | -$8.88K | ﹤0.01% | 3072 |
|
|
2021
Q3 | $68K | Buy |
2,187
+154
| +8% | +$4.79K | ﹤0.01% | 3325 |
|
|
2021
Q2 | $111K | Sell |
2,033
-108
| -5% | -$5.9K | ﹤0.01% | 3107 |
|
|
2021
Q1 | $126K | Buy |
+2,141
| New | +$126K | ﹤0.01% | 3297 |
|
|
2020
Q4 | – | Sell |
-321
| Closed | -$17K | – | 3555 |
|
|
2020
Q3 | $17K | Sell |
321
-895
| -74% | -$47.4K | ﹤0.01% | 3501 |
|
|
2020
Q2 | $305K | Buy |
1,216
+1,213
| +40,433% | +$304K | ﹤0.01% | 2596 |
|
|
2020
Q1 | $0 | Sell |
3
-1
| -25% | – | ﹤0.01% | 3683 |
|
|
2019
Q4 | $0 | Sell |
4
-1,220
| -100% | – | ﹤0.01% | 3907 |
|
|
2019
Q3 | $179K | Sell |
1,224
-1,176
| -49% | -$172K | ﹤0.01% | 3109 |
|
|
2019
Q2 | $499K | Buy |
2,400
+290
| +14% | +$60.3K | ﹤0.01% | 2719 |
|
|
2019
Q1 | $440K | Buy |
2,110
+1,809
| +601% | +$377K | ﹤0.01% | 2688 |
|
|
2018
Q4 | $52K | Buy |
301
+296
| +5,920% | +$51.1K | ﹤0.01% | 3163 |
|
|
2018
Q3 | $1K | Sell |
5
-358
| -99% | -$71.6K | ﹤0.01% | 4224 |
|
|
2018
Q2 | $54K | Sell |
363
-580
| -62% | -$86.3K | ﹤0.01% | 3268 |
|
|
2018
Q1 | $172K | Buy |
943
+663
| +237% | +$121K | ﹤0.01% | 2914 |
|
|
2017
Q4 | $60K | Sell |
280
-653
| -70% | -$140K | ﹤0.01% | 3273 |
|
|
2017
Q3 | $200K | Buy |
933
+532
| +133% | +$114K | ﹤0.01% | 2392 |
|
|
2017
Q2 | $76K | Sell |
401
-992
| -71% | -$188K | ﹤0.01% | 2873 |
|
|
2017
Q1 | $345K | Sell |
1,393
-400
| -22% | -$99.1K | ﹤0.01% | 2172 |
|
|
2016
Q4 | $454K | Buy |
+1,793
| New | +$454K | ﹤0.01% | 1875 |
|